Interested in investing?
If you are interested in investing drop us an email at investors@adherium.com. Adherium is listed on the ASX market, the primary registered stock exchange in Australia operated by ASX Limited. Our ticker symbol is ADR. For most stock-tracking software, including mobile phone apps, use the symbol ADR.AX
Investor information
Adherium Limited’s wholly owned subsidiary*, Adherium (NZ) (formerly Nexus6 Limited), was incorporated in 2001 by CEO, Garth Sutherland.
As someone who has lived with severe asthma his whole life, Garth established the Company to use his technical and engineering expertise to develop a product that could help him manage his own condition, andthereby help others facing the same challenges.
The first Smartinhaler™ was developed for use in clinical trials in 2003, and since then the company has expanded its technology platform and Smartinhaler™ product range. Adherium now has the broadest range of “smart” devices for inhaled drug delivery devices.
Investors & Partners
Latest Announcements
- Notice of Annual General Meeting/Proxy Form 27/10/2017
- Adherium Q1 FY18 Investor Conference Call details 25/10/2017
- Adherium Appoints VP Marketing 10/10/2017
- Adherium Annual Report June 2017 29/09/2017
- Appendix 4G 29/09/2017
- Adherium Appoints New CFO 19/09/2017
- Change of Director’s Interest Notice (escrow release) 04/09/2017
- Change of Director’s Interest Notice (escrow release) 04/09/2017
Corporate Governance
Please click on the links below to view key Corporate Governance information: